Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab

BACKGROUND: Interferon-beta (IFN-beta) is one of the most widely prescribed medications for relapsing-remitting multiple sclerosis (RRMS). IFN-related thrombotic microangiopathy (TMA) is a rare but severe complication, with a fulminant clinical onset and a possibly life-threatening outcome that may...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Kidney J
Glavni autori: Allinovi, Marco, Cirami, Calogero Lino, Caroti, Leonardo, Antognoli, Giulia, Farsetti, Silvia, Amato, Maria Pia, Minetti, Enrico Eugenio
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Thrombotic Microangiopathy
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5622889/
https://ncbi.nlm.nih.gov/pubmed/28980667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfw143
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items